Intercept Pharmaceuticals, Inc. (ICPT): Price and Financial Metrics
Intercept Pharmaceuticals, Inc. (ICPT)
Today's Latest Price: $48.04 USD
Updated Aug 5 8:00pm
Add ICPT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ICPT Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ICPT is -7.85 -- better than only 2.24% of US stocks.
- ICPT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 91.61% of US stocks.
- Revenue growth over the past 12 months for Intercept Pharmaceuticals Inc comes in at 38.91%, a number that bests 87.09% of the US stocks we're tracking.
- Stocks that are quantitatively similar to ICPT, based on their financial statements, market capitalization, and price volatility, are IRWD, RDUS, BNFT, FLXN, and TTOO.
- ICPT's SEC filings can be seen here. And to visit Intercept Pharmaceuticals Inc's official web site, go to www.interceptpharma.com.
ICPT Stock Price Chart Technical Analysis Charts
ICPT Price/Volume Stats
| Current price | $48.04 | 52-week high | $125.00 |
| Prev. close | $47.58 | 52-week low | $42.19 |
| Day low | $47.40 | Volume | 777,560 |
| Day high | $49.20 | Avg. volume | 764,484 |
| 50-day MA | $60.49 | Dividend yield | N/A |
| 200-day MA | $82.24 | Market Cap | 1.58B |
Intercept Pharmaceuticals, Inc. (ICPT) Company Bio
Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic underserved liver diseases. The company was founded in 2002 and is based in New York, New York.
Loading social stream, please wait...